Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell.

The ras oncogene needs a second factor to induce transformation and tumorigenicity of the cell. In this study, we show that mouse fibroblast 7-4-Stat3C cells overexpressing both Ha-ras(val12) oncogene and active-form Stat3 (Stat3C) showed higher colony formation in soft agar and xenograft tumor growth in BALB/c mice. Further studies show that both serine-727 and tyrosine-705 of Stat3 were phosphorylated while Ha-ras was overexpressed. Interleukin-6 (IL-6)-induced phosphorylation of tyrosine-705 and serine-727, as well as DNA-binding and transcriptional activity of Stat3 were further enhanced by Ha-ras overexpression. In addition, overexpression of Stat3C in 7-4-Stat3C cells prevented the cells from morphological change and apoptosis triggered by the Ha-ras oncogene under serum-depleted conditions. We demonstrate that Ha-ras and Stat3 acting together synergistically induce Stat3 phosphorylation at serine-727 phosphorylation and cyclin D1 expression and further enhance transformation and tumorigenicity of the cell. Ha-ras-induced Stat3 phosphorylation at serine-727 plays a pivotal role in transcriptional activation of cyclin D1 and suppression of cell apoptosis. The effect of Ha-ras on Stat3 phosphorylation at serine-727 was also detected in human bladder (T24) and lung (H460) cancer cells. Stat3 phosphorylation at serine-727 is important in Ras-related tumorigenesis.

[1]  E. Hurt,et al.  Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. , 2008, Cancer research.

[2]  T. Uchida,et al.  Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity , 2007, Oncogene.

[3]  G. Wilding,et al.  Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. , 2007, Cancer research.

[4]  H. Hollema,et al.  Ras/ERK1/2-mediated STAT3 Ser727 Phosphorylation by Familial Medullary Thyroid Carcinoma-associated RET Mutants Induces Full Activation of STAT3 and Is Required for c-fos Promoter Activation, Cell Mitogenicity, and Transformation* , 2007, Journal of Biological Chemistry.

[5]  Helen H. W. Chen,et al.  Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion , 2006, Oncogene.

[6]  S. Pelech,et al.  Phosphorylation of STAT3 serine-727 by cyclin-dependent kinase 1 is critical for nocodazole-induced mitotic arrest. , 2006, Biochemistry.

[7]  K. Venkatasubbarao,et al.  Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases. , 2005, Cancer research.

[8]  Saïd M. Sebti,et al.  Searching for the elusive targets of farnesyltransferase inhibitors , 2003, Nature Reviews Cancer.

[9]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[10]  D. Levy,et al.  What does Stat3 do? , 2002, The Journal of clinical investigation.

[11]  T. Hirano,et al.  The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway , 2001, Oncogene.

[12]  A. Smrcka,et al.  Phospholipase Cϵ: a novel Ras effector , 2001 .

[13]  J. Bromberg.  Activation of STAT proteins and growth control , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  J. Turkson,et al.  STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.

[15]  J. Turkson,et al.  Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling , 2000, Oncogene.

[16]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[17]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[18]  S. Pestka,et al.  Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes , 2000, Oncogene.

[19]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[20]  P. Coffer,et al.  The role of STATs in myeloid differentiation and leukemia , 2000, Oncogene.

[21]  C. Der,et al.  Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.

[22]  J. Turkson,et al.  Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein , 1999, Molecular and Cellular Biology.

[23]  Xinmin Cao,et al.  Serine Phosphorylation and Negative Regulation of Stat3 by JNK* , 1999, The Journal of Biological Chemistry.

[24]  I. Su,et al.  Plasmid harboring lac repressor and tTA activator genes can regulate two inducible genes in mammalian cells. , 1999, BioTechniques.

[25]  C. Dearolf.  JAKs and STATs in invertebrate model organisms , 1999, Cellular and Molecular Life Sciences CMLS.

[26]  Tong Zhang,et al.  Protein Kinase C δ Associates with and Phosphorylates Stat3 in an Interleukin-6-dependent Manner* , 1999, The Journal of Biological Chemistry.

[27]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[28]  J. O'flaherty,et al.  Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines. , 1999, The Biochemical journal.

[29]  Xinmin Cao,et al.  Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK) , 1998, Oncogene.

[30]  T. Hirano,et al.  Activation of Stat3 by v-Src Is through a Ras-Independent Pathway , 1998, Journal of Biomedical Science.

[31]  J. Darnell.  Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[32]  C-Y Chen,et al.  Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells , 1998, British Journal of Cancer.

[33]  R. Jove,et al.  Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. , 1998, Journal of biomedical science.

[34]  J. Turkson,et al.  Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation , 1998, Molecular and Cellular Biology.

[35]  J. Blenis,et al.  STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation , 1997, Molecular and cellular biology.

[36]  C. Horvath,et al.  Signal transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras/Raf/MEK-dependent pathway. , 1997, Endocrinology.

[37]  D. Cantrell,et al.  STAT3 Is a Serine Kinase Target in T Lymphocytes , 1997, The Journal of Biological Chemistry.

[38]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[39]  J. Ihle.  Cytokine receptor signalling , 1995, Nature.

[40]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[41]  N. Stahl,et al.  STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Ng,et al.  Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells , 1995, Molecular and cellular biology.

[43]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.

[44]  Sally J. Leevers,et al.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane , 1994, Nature.

[45]  M. Lieberman,et al.  Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. , 1992, Cancer research.

[46]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[47]  H. Izumi,et al.  Oncogenic Ras-induced morphologic change is through MEK/ERK signaling pathway to downregulate Stat3 at a posttranslational level in NIH3T3 cells. , 2008, Neoplasia.

[48]  T. Uchida,et al.  Pin 1 is required for the Ser 727 phosphorylation-dependent Stat 3 activity , 2007 .

[49]  A. Smrcka,et al.  Phospholipase C(epsilon): a novel Ras effector. , 2001, The EMBO journal.

[50]  J. Avruch,et al.  Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR , 2000, Current Biology.

[51]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[52]  厨子 慎一郎.  STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells , 1998 .

[53]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.